International

WHO Expert Committee on Specifications for Pharmaceutical Preparations 57th Report

The WHO Expert Committee on Specifications for Pharmaceutical Preparations has released its 57th report, recommending new and revised guidance texts for pharmaceutical quality assurance. These include updated GMP for excipients, new GMP for radiopharmaceutical cold kits, revised lab quality control practices, and updated biowaiver guidelines.

WHO Expert Committee Adopts New Pharmaceutical Guidance

The WHO Expert Committee on Specifications for Pharmaceutical Preparations has adopted nine new guidance texts aimed at ensuring the quality assurance of medicines. These texts cover areas such as nitrosamine prevention, good manufacturing practices for excipients, and bioequivalence assessments, and are recommended for implementation.

WHO Expert Committee on Pharmaceutical Preparations Meeting

The World Health Organization (WHO) announced the Sixtieth meeting of the Expert Committee on Specifications for Pharmaceutical Preparations, scheduled for October 12-16, 2026. This committee advises the Director-General on medicine quality assurance and the maintenance of The International Pharmacopoeia.

ICH Guidelines Overview

The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) provides guidelines across quality, safety, efficacy, and multidisciplinary areas. These guidelines aim to harmonize technical requirements for pharmaceutical registration globally.

ICH Q1A(R2) Stability Testing Guideline Finalized

The International Council for Harmonisation (ICH) has finalized its Q1A(R2) guideline on stability testing of new drug substances and products. This revised guideline, effective February 6, 2003, provides updated recommendations for stability testing protocols across different climatic zones.

Public Consultations on Drug Development Guidelines

The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is seeking public input on proposed guidelines related to drug development standards. This consultation aims to gather feedback on new and revised guidelines before their finalization.

PCI SSC Establishes India-South Asia Regional Engagement Board

The PCI Security Standards Council (PCI SSC) has established its first Regional Engagement Board (REB) for the India and South Asia region, effective for 2025-2026. The board comprises 27 organizations from the payment industry to advise on payment security issues and promote awareness of PCI SSC standards.

PCI SSC Meeting Advances Payment Security and AI Guidance

The PCI Security Standards Council held its North America Community Meeting, focusing on advancing payment security and launching AI guidance. The event brought together over 1,200 stakeholders to discuss evolving standards, best practices for AI in payments, and cross-industry collaboration.

PCI SSC Asia-Pacific Community Meeting on Payment Security

The PCI Security Standards Council (PCI SSC) is hosting its annual Asia-Pacific Community Meeting in Bangkok on November 5-6, 2025. The event will bring together payment security experts to discuss evolving threats, new technologies, and best practices for preventing cyberattacks and fraud in the region.

PCI Security Standards Council Publishes Inaugural Annual Report

The PCI Security Standards Council has released its first-ever Annual Report, detailing progress in payment security during 2025 and outlining its vision for 2026. The report highlights advancements in standards, global collaboration, and the adoption of a product-led operating model.